H1N1 Swine Flu Update - Anaphylaxis Has Also Occurred in MMR & HPV Vaccines
There seems to be no way to predict which individuals will have an allergic reaction of anaphylaxis to any one specific vaccine. All of the H1N1 Mexican Swine Flu vaccine that was utilized in Canada was produced and cultured in eggs. It is feasible that any residual protein from the egg in the vaccine itself could provoke in individuals who already have pre-existing egg allergies and cause an allergic response leading to anaphylaxis.
There have been cases in other vaccines such as the combined vaccine for mumps, measles and rubella that an antibiotic which was utilized in the production of that vaccine has sparked severe reactions in individuals receiving that particular MMR vaccine. It is difficult to determine which particular mechanism would allow for a spike in the reporting of anaphylaxis allergic reactions in any specific lot of vaccine, be it for MMR, HPV, or H1N1.
The logical conclusion that that particular batch from Glaxo Smith Kline of H1N1 Mexican Swine flu vaccine had a greater percentage of a particular substance within it that was the trigger for the higher expected and higher than average rate of anaphylaxis reactions. This proves that the current state of H1N1 vaccine is far from being foolproof and anyone contemplating have the H1N1 Mexican Swine Flu Virus vaccine shot should consider their decision very carefully and meticulously weigh their alternatives.
It must be stated that the vaccine that is currently being utilized in the United States against the H1N1 Mexican Swine Flu Virus has an excellent safety profile and the systems which the Centers For Disease Control & Prevention is using for tracking the efficacy and safety of the vaccine have not shown significant red flags to date.
It is important to note that significant changes in the profile of the viral pandemic have occurred in the last couple weeks which may indicate that there are changes in the overall profile, however, due to the information at this time it cannot be significantly concluded that there is a link towards creating a warning against the use of the vaccine. As of this time that situation seems stable.
One of the common factors that have been discovered in the onset of H1N1 severe illness and fatality is the co-infection of bacteria. The co-infections particularly work in paediatric environment as a function of an influenza virus which is causing a disease within a child becomes much more severe when a common infection which is originated from bacteria is present in the child and then a severe case of pneumonia develops.
The staphylococcus aureus and the pneumococcus bacteria have been implicated in some of these cases. The southwest pneumococcal vaccine is susceptible to antibiotics and the administration of these anti bacterial agents can help prevent fatalities in children and adults that are in high risk demographic groups.
Disclaimer: The information on this Hub page does not constitute medical, legal, commercial, product, and/or service advice or endorsement of any vendor, supplier and/or brand, and does not necessarily reflect the opinion of the author. Listing of an entity or service on this Hub page is not a warranty of the quality or efficacy of the products or services furnished by any entity. The author is not directly compensated by any entity other than the advertising placement services shown on this page.